亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

熱銷(xiāo)奧美拉唑鈉,奧美拉唑鈉原料藥經(jīng)銷(xiāo)商

 
 
單價(jià) 1.00 / 千克對(duì)比
銷(xiāo)量 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫(kù)存 5000千克起訂25千克
品牌 帝鑫
過(guò)期 長(zhǎng)期有效
更新 2016-01-14 16:08
 

湖北省帝鑫化工制造有限公司

企業(yè)會(huì)員第12年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2016-01-14
  • 胡鑫 (先生)   銷(xiāo)售經(jīng)理
詳細(xì)說(shuō)明
 產(chǎn)品名稱:奧美拉唑鈉
中文別名:奧美拉唑鈉鹽;5-甲氧基-2-[(4-甲氧基-3,5-二甲基-2-吡啶基)-甲基亞砜]-3H-苯并咪唑鈉鹽  
英文名稱: Omeprazole sodium 
英文名稱:sodium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzoimidazole
 
 
CAS登錄號(hào):95510-70-6
分子式:C17H18N3NAO3S
分子量:367.4
MOL File: 95510-70-6.mol
雜質(zhì)C ≤0.1%
單個(gè)雜質(zhì)≤0.1%
干燥失重 4.5%-10.0%
重金屬 ≤20ppm
含 量 98.0%-101.0% 
 
性狀:該品為白色疏松塊狀物或粉末,專用溶劑為無(wú)色的透明液體。
 
用途:主要用于消化性潰瘍出血、吻合口潰瘍出血。亦常用于預(yù)防重癥疾病(如重創(chuàng)傷等),胃手術(shù)后預(yù)防再出血等。
 
包裝:1KG/袋或25KG/紙板桶
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |